Clinical Trial Update: CKD-828 Telmisartan Non-Responder Trial [Phase 3]

View source ↗

Summary

A completed Phase 3 trial conducted by Chong Kun Dang Pharmaceutical evaluating CKD-828 in telmisartan non-responders for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-828
• Telmisartan (Telmisartan)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 3 | Status: COMPLETED